Cited by 3,163Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulation

The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.

Blinded by the Light: The Growing Complexity of p53

Open access

Vousden, Karen H., Prives, Carol·2009·Cell

DOI 10.1016/j.cell.2009.04.037

Open this paper in CoChat — free account Open PDF

Abstract

While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2009.04.037

Cites

231 of 231 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
Retracted
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Self-citation
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921

Flagged first, then by citations

Show all 232 references

1 of the 232 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 1,016

The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
Reuven, N. B., Adler, J., Meltser, V., & Shaul, Y. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.83 · Cited by 70
Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells
Hasei, J., Sasaki, T., Tazawa, H., Osaki, S., Yamakawa, Y., Kunisada, T., Yoshida, A., Hashimoto, Y., Onishi, T., Uno, F., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0869 · Cited by 70
p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses
Hünten, S., Kaller, M., Drepper, F., Oeljeklaus, S., Bonfert, T., Erhard, F., Dueck, A., Eichner, N., Friedel, C. C., Meister, G., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.050237 · Cited by 70
Novel p53 target gene FUCA 1 encodes a fucosidase and regulates growth and survival of cancer cells
Ezawa, I., Sawai, Y., Kawase, T., Okabe, A., Tsutsumi, S., Ichikawa, H., Kobayashi, Y., Tashiro, F., Namiki, H., Kondo, T., et al. (2016) · Cancer Science · doi:10.1111/cas.12933 · Cited by 70
Decreased DJ-1 Leads to Impaired Nrf2-Regulated Antioxidant Defense and Increased UV-A–Induced Apoptosis in Corneal Endothelial Cells
Cai-ling, L., Chen, Y.-M., Kochevar, I. E., & Jurkunas, U. V. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14580 · Cited by 70
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis
Cordani, M., Pacchiana, R., Butera, G., D’Orazi, G., Scarpa, A., & Donadelli, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.046 · Cited by 70
Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7
Zhao, K., Yang, Y., Zhang, G., Wang, C., Wang, D., Wu, M., & Mei, Y. (2018) · EMBO Reports · doi:10.15252/embr.201744465 · Cited by 70
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
de Cárcer, G. (2019) · Genes · doi:10.3390/genes10030208 · Cited by 70
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69
At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity
Rizzotto, D., Englmaier, L., & Villunger, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910883 · Cited by 69
Repression of P53 Function by SIRT5-Mediated Desuccinylation at Lysine 120
Liu, X., Rong, F., Tang, J., Zhu, C., Chen, X., Jia, S., Wang, Z., Sun, X., Deng, H., Zha, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-021-00886-w · Cited by 72
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
Hou, Y., Zhang, X., Yao, H., Hou, L., Zhang, Q., Tao, E., Zhu, X., Jiang, S., Ren, Y., Hong, X., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256325 · Cited by 69
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy
Cipriani, P., Benedetto, P. D., Liakouli, V., Papa, B. D., Padova, M. D., Ianni, M. D., Marrelli, A., Alesse, E., & Giacomelli, R. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12111 · Cited by 69
USP11 regulates p53 stability by deubiquitinating p53
Ke, J., Dai, C., Wu, W.-L., Gao, J., Xia, A.-J., Liu, G., Lv, K., & Wu, C. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400180 · Cited by 69
Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells
Zhu, H., Yang, K. G., Xie, Y.-Q., Lin, Y.-W., Mao, Q., & Xie, L. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-22 · Cited by 69
Nuclear Pore Component Nup98 Is a Potential Tumor Suppressor and Regulates Posttranscriptional Expression of Select p53 Target Genes
Singer, S., Zhao, R., Barsotti, A. M., Ouwehand, A., Fazollahi, M., Coutavas, E. E., Breuhahn, K., Neumann, O., Longerich, T., Pusterla, T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.020 · Cited by 69
Self-citation
Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression
Zakraoui, O., Marcinkiewicz, C., Aloui, Z., Othman, H., Grépin, R., Haoues, M., Essafi, M., Srairi‐Abid, N., Gasmi, A., Karoui, H., et al. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22470 · Cited by 69
Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells
Matsumoto, M., Nakajima, W., Seike, M., Gemma, A., & Tanaka, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.053 · Cited by 69
Role of SOX family of transcription factors in central nervous system tumors.
de la Rocha, A. A., Samprón, N., Alonso, M. M., & Matheu, A. (2014) · Europe PMC (PubMed Central) · Cited by 68
Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 69
Role of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 69
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT
Wei, J., Xiao, M., Mao, Z., Wang, N., Cao, Y., Xiao, Y., Meng, F., Sun, W., Wang, Y., Yang, X., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00924-0 · Cited by 68
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
Zhao, K., Zhou, Y., Qiao, C., Ni, T., Li, Z., Wang, X., Guo, Q., Lu, N., & Wei, L. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0137-1 · Cited by 68
Chloroquine Promotes Apoptosis in Melanoma Cells by Inhibiting BH3 Domain–Mediated PUMA Degradation
Lakhter, A. J., Sahu, R. P., Sun, Y., Kaufmann, W. K., Androphy, E. J., Travers, J. B., & Naidu, S. R. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.56 · Cited by 68
Wild type p53 reactivation: From lab bench to clinic
Selivanova, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.049 · Cited by 68
Tumor suppressors: enhancers or suppressors of regeneration?
Pomerantz, J. H., & Blau, H. M. (2013) · Development · doi:10.1242/dev.084210 · Cited by 68
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation
Andrysík, Z., Kim, J., Tan, A. C., & Espinosa, J. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.014 · Cited by 68
hSSB1 regulates both the stability and the transcriptional activity of p53
Xu, S., Wu, Y., Chen, Q., Cao, J., Hu, K., Tang, J., Sang, Y., Lai, F., Wang, L., Zhang, R., et al. (2012) · Cell Research · doi:10.1038/cr.2012.162 · Cited by 68
The beneficial effects of Zn on Akt-mediated insulin and cell survival signaling pathways in diabetes
Sun, W., Yang, J., Wang, W., Hou, J., Cheng, Y., Fu, Y., Xu, Z., & Cai, L. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.005 · Cited by 68
ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53
Sullivan, K. D., Padilla-Just, N., Henry, R. E., Porter, C. C., Kim, J., Tentler, J. J., Eckhardt, S. G., Tan, A. C., DeGregori, J., & Espinosa, J. M. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.965 · Cited by 67
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation
Cao, Z., Kon, N., Liu, Y., Xu, W., Wen, J., Yao, H., Zhang, M., Wu, Z., Yan, X., Zhu, W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf4148 · Cited by 67
Structural diversity of p63 and p73 isoforms
Osterburg, C., & Dötsch, V. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00975-4 · Cited by 67
Lymphocyte Development: Integration of DNA Damage Response Signaling
Bednarski, J. J., & Sleckman, B. P. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00006-5 · Cited by 66
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
Tacar, O., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12144 · Cited by 67
A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression
Yamasaki, Y., Tazawa, H., Hashimoto, Y., Kojima, T., Kuroda, S., Yano, S., Yoshida, R., Uno, F., Mizuguchi, H., Ohtsuru, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.020 · Cited by 67
The WTX Tumor Suppressor Enhances p53 Acetylation by CBP/p300
Kim, W. J., Rivera, M. N., Coffman, E. J., & Haber, D. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.025 · Cited by 67
Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ
Bersani, C., Xu, L., Vilborg, A., Lui, W., & Wiman, K. G. (2014) · Oncogene · doi:10.1038/onc.2013.594 · Cited by 67
TP53mutations are frequent events in double-hit B-cell lymphomas withMYCandBCL2but notMYCandBCL6translocations
Gebauer, N., Bernard, V., Gebauer, W., Thorns, C., Feller, A. C., & Merz, H. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.907896 · Cited by 67
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis
Asano, Y., Kawase, T., Okabe, A., Tsutsumi, S., Ichikawa, H., Tatebe, S., Kitabayashi, I., Tashiro, F., Namiki, H., Kondo, T., et al. (2016) · Scientific Reports · doi:10.1038/srep19174 · Cited by 67
Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions
Yang, Y. P., Peng, J., Sanjun, C., & Ma, Y. (2017) · Journal of Cancer · doi:10.7150/jca.19794 · Cited by 67
Autophagy in endometriosis.
Yang, H., Mei, J., Chang, K., Zhou, W., Huang, L., & Li, M. (2017) · Europe PMC (PubMed Central) · Cited by 73
Cell Fate Regulation upon DNA Damage: p53 Serine 46 Kinases Pave the Cell Death Road
Liebl, M. C., & Hofmann, T. G. (2019) · BioEssays · doi:10.1002/bies.201900127 · Cited by 67
The p53/microRNA Network in Cancer: Experimental and Bioinformatics Approaches
Hünten, S., Siemens, H., Kaller, M., & Hermeking, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_5 · Cited by 66
Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance
Xu, J., Patel, N. H., & Gewirtz, D. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238991 · Cited by 66
Discovery of a Potent and Selective Degrader for USP7
Pei, Y., Fu, J., Shi, Y., Zhang, M., Luo, G., Luo, X., Song, N., Mi, T., Yang, Y., Li, J. X., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204395 · Cited by 68
Advances in adenovirus-mediated p53 cancer gene therapy
Tazawa, H., Kagawa, S., & Fujiwara, T. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.845662 · Cited by 66
PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges
Liu, L., & Pilch, P. F. (2016) · eLife · doi:10.7554/elife.17508 · Cited by 66
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Olivos, D. J., & Mayo, L. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121982 · Cited by 67
Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation
Purbey, P. K., Scumpia, P. O., Kim, P. J., Tong, A.-J., Iwamoto, K. S., McBride, W. H., & Smale, S. T. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.017 · Cited by 66
p53’s Extended Reach: The Mutant p53 Secretome
Pavlakis, E., & Stiewe, T. (2020) · Biomolecules · doi:10.3390/biom10020307 · Cited by 66
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant high-grade serous ovarian cancer
Fransson, Å., Glaessgen, D., Alfredsson, J., Wiman, K. G., Bajalica-Lagercrantz, S., & Mohell, N. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0239-6 · Cited by 65
A genome‐wide si RNA screen for regulators of tumor suppressor p53 activity in human non‐small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment
Olst, E. S., Blijlevens, M., de Menezes, R. X., van der Meulen‐Muileman, I. H., Smit, E. F., & van Beusechem, V. W. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12052 · Cited by 65
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53‐ALOX15 signaling pathway
Li, D., Lu, X., Xu, G., Liu, S., Gong, Z., Lu, F., Xia, X., Jiang, J., Wang, H., Zou, F., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14150 · Cited by 65
Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
Liu, T., Han, S., Yao, Y., & Zhang, G. (2023) · Cancer Management and Research · doi:10.2147/cmar.s421771 · Cited by 65
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Wu, M., Zhao, Y., Zhang, C., & Pu, K. (2024) · ACS Nano · doi:10.1021/acsnano.4c09800 · Cited by 65
Illuminating p53 function in cancer with genetically engineered mouse models
Garcia, P. B., & Attardi, L. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.014 · Cited by 65
MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs
Peche, L. Y., Scolz, M., Ladelfa, M. F., Monte, M., & Schneider, C. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.173 · Cited by 65
DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability
Qin, B., Minter‐Dykhouse, K., Yu, J., Zhang, J., Liu, T., Zhang, H., Lee, S., Kim, J.-J., Wang, L., & Lou, Z. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.066 · Cited by 65
Sliding of p53 along DNA Can Be Modulated by Its Oligomeric State and by Cross-Talks between Its Constituent Domains
Khazanov, N., & Levy, Y. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.059 · Cited by 65
Integrated high-throughput analysis identifies Sp1 as a crucial determinant of p53-mediated apoptosis
Li, H., Zhang, Y., Ströse, A., Tedesco, D., Gurova, K. V., & Selivanova, G. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.69 · Cited by 65
Mevalonate metabolism in cancer
Gruenbacher, G., & Thurnher, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.013 · Cited by 65
Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53
Goldstein, I., Rivlin, N., Shoshana, O.-Y., Ezra, O., Madar, S., Goldfinger, N., & Rotter, V. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs318 · Cited by 65
Transcriptional Regulation of thep53Tumor Suppressor Gene in S-Phase of the Cell-Cycle and the Cellular Response to DNA Damage
Reisman, D., Takahashi, P., Polson, A., & Boggs, K. (2012) · Biochemistry Research International · doi:10.1155/2012/808934 · Cited by 65
Sestrins at the crossroad between stress and aging
Lee, J. H., Bodmer, R., Bier, E., & Karin, M. (2010) · Aging · doi:10.18632/aging.100157 · Cited by 65
Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System
Hat, B., Kochańczyk, M., Bogdał, M. N., & Tomasz Lipniacki, B. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004787 · Cited by 65
Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage
Finzel, A., Grybowski, A., Strasen, J., Cristiano, E., & Loewer, A. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0032 · Cited by 65
Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit
Cao, B., Fang, Z., Liao, P., Zhou, X. Y., Xiong, J., Zeng, S. X., & Lu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21544 · Cited by 65
p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine
Krstić, J., Galhuber, M., Schulz, T. J., Schupp, M., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030921 · Cited by 65
Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy
Simon, C. M., Alstyne, M. V., Lotti, F., Bianchetti, E., Tisdale, S., Watterson, D. M., Mentis, G. Z., & Pellizzoni, L. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.058 · Cited by 65
Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1Preprint
Zhang, M., Zhang, J., Chen, X., Cho, S.-J., & Chen, X. (2013) · Genes & Development · doi:10.1101/gad.221739.113 · Cited by 65
MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3
Sanchez, N., Gallagher, M., Lao, N. T., Gallagher, C., Clarke, C., Doolan, P., Aherne, S. T., Blanco, A., Meleady, P., CLYNES, M. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065671 · Cited by 64
Loss of Nucleolar Histone Chaperone NPM1 Triggers Rearrangement of Heterochromatin and Synergizes with a Deficiency in DNA Methyltransferase DNMT3A to Drive Ribosomal DNA Transcription
Olausson, K. H., Nistér, M., & Lindström, M. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.569244 · Cited by 64
More targets, more pathways and more clues for mutant p53
Garritano, S., Inga, A., Gemignani, F., & Landi, S. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.15 · Cited by 64
The p53–PUMA axis suppresses iPSC generation
Li, Y., Feng, H., Gu, H., Lewis, D. W., Yuan, Y., Zhang, L., Yu, H. M., Zhang, P., Cheng, H., Miao, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3174 · Cited by 64
Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
Surget, S., Chiron, D., Gomez‐Bougie, P., Descamps, G., Ménoret, E., Bataille, R., Moreau, P., Gouill, S. L., Amiot, M., & Pellat‐Deceunynck, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0487 · Cited by 64
Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome
Mirzayans, R., Andrais, B., Kumar, P., & Murray, D. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050928 · Cited by 64
Comparative transcriptome analysis of ovary and testis reveals potential sex-related genes and pathways in spotted knifejaw Oplegnathus punctatus
Du, X., Wáng, B., Liu, X., Liu, X., He, Y., Zhang, Q., & Wang, X. (2017) · Gene · doi:10.1016/j.gene.2017.09.055 · Cited by 64
Structural and Drug Targeting Insights on Mutant p53
Gomes, A. S., Ramos, H., Inga, A., Sousa, E., & Saraiva, L. (2021) · Cancers · doi:10.3390/cancers13133344 · Cited by 63
Mitochondrial Oxidative Stress and Cell Death in Podocytopathies
Zhu, Y., Wan, C., Lin, J., Hammes, H., & Zhang, C. (2022) · Biomolecules · doi:10.3390/biom12030403 · Cited by 63
Alterations of p63 and p73 in Human Cancers
Inoue, K., & Fry, E. A. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_2 · Cited by 63
Molecular markers for colon diagnosis, prognosis and targeted therapy
Herzig, D. O., & Tsikitis, V. L. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23806 · Cited by 63
p53 in the Myeloid Lineage Modulates an Inflammatory Microenvironment Limiting Initiation and Invasion of Intestinal Tumors
He, X., Xiang, C., Zhang, C.-X., Xie, Y., Chen, L., Zhang, G.-X., Lu, Y., & Liu, G. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.045 · Cited by 64
Genome analysis of the new human polyomaviruses
Ghelue, M. V., Khan, M. T. H., Ehlers, B., & Moens, U. L. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.1711 · Cited by 63
AKT‐dependent phosphorylation of Niban regulates nucleophosmin‐ and MDM2‐mediated p53 stability and cell apoptosis
Ji, H., Ding, Z., Hawke, D. H., Xing, D., Jiang, B., Mills, G. B., & Lu, Z. (2012) · EMBO Reports · doi:10.1038/embor.2012.53 · Cited by 63
Chemokine receptor CXCR 2 is transactivated by p53 and induces p38‐mediated cellular senescence in response to DNA damage
Guo, H., Liu, Z., Xu, B., Hu, H., Wei, Z., Liu, Q., Zhang, X., Ding, X., Wang, Y., Zhao, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12138 · Cited by 63
Mapping the Structural and Dynamical Features of Multiple p53 DNA Binding Domains: Insights into Loop 1 Intrinsic Dynamics
Lukman, S., Lane, D. P., & Verma, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080221 · Cited by 63
Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats
Yu, W., Wan, Z., Qiu, X., Chen, Y., & Dai, Y. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.60 · Cited by 63
Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
Burmakin, M., Shi, Y., Hedström, E., Kogner, P., & Selivanova, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2211 · Cited by 63
p53 integrates host defense and cell fate during bacterial pneumonia
Madenspacher, J. H., Azzam, K. M., Gowdy, K. M., Malcolm, K. C., Nick, J. A., Dixon, D., Aloor, J. J., Draper, D. W., Guardiola, J. J., Shatz, M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121674 · Cited by 63
The principle of conformational signaling
Tompa, P. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00011h · Cited by 63
p53 and TAp63 participate in the recombination-dependent pachytene arrest in mouse spermatocytes
Marcet-Ortega, M., Pacheco, S., Martínez-Marchal, A., Castillo‐Ecija, H., Flores, E. R., Jasin, M., Keeney, S., & Roig, I. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006845 · Cited by 63
p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1
Quiñones, M., Al–Massadi, O., Folgueira, C., Bremser, S., Gallego, R., Torres‐Leal, F. L., Haddad-Tóvolli, R., García‐Cáceres, C., Hernández-Bautista, R., Lam, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05711-6 · Cited by 63
Haploinsufficient tumor suppressor genes.
Inoue, K., & Fry, E. A. (2017) · PubMed · Cited by 64
Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma
Simon, D. P., & Hammer, G. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.006 · Cited by 62
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
Weilbacher, A., Gutekunst, M., Oren, M., Aulitzky, W. E., & van der Kuip, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.284 · Cited by 62
TIGAR regulates glycolysis in ischemic kidney proximal tubules
Kim, J., Devalaraja-Narashimha, K. B., & Padanilam, B. J. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00459.2014 · Cited by 62
RNF43 interacts with NEDL1 and regulates p53-mediated transcription
Shinada, K., Tsukiyama, T., Sho, T., Okumura, F., Asaka, M., & Hatakeyama, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.082 · Cited by 62
Clinical utility of anti-p53auto-antibody: Systematic review and focus on colorectal cancer
Suppiah, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i29.4651 · Cited by 62
Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells
Pandit, B., & Gartel, A. L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.010 · Cited by 62

Authors: Vousden, K. H., & Prives, C.
Affiliations: Cancer Research UK Scotland Institute (GB)
Columbia University (US)
Corresponding author: Vousden, Karen H.
Prives, Carol
ORCID: Vousden, Karen H.
Prives, Carol
Venue: Cell
Publisher: Elsevier BV
Published: 2009-05
Volume: 137
Issue: 3
Pages: 413-431
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2009.04.037
OpenAlex: W2133959309
Semantic Scholar: 018e8ed8c8694d45cfd9ffaf967368345fe22af6
Cited by: 3,163
References: 232
Citations by year: 2026: 128 · 2025: 154 · 2024: 127 · 2023: 168 · 2022: 149 · 2021: 166 · 2020: 175 · 2019: 149 · 2018: 171 · 2017: 191 · 2016: 228 · 2015: 202 · 2014: 258 · 2013: 263 · 2012: 228
FWCI: 17.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1538 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
National Cancer Institute (R01CA077742, CA77742)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, transcriptional activation, p53 activators, p53 inhibitors, p53 regulation
MeSH terms: Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Mutation, Stress, Physiological, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Blinded by the Light: The Growing Complexity of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks